Clifford JL - Search Results

1

Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.

Brewster AM, Lee JJ, Clayman GL, Clifford JL, Reyes MJ, Zhou X, Sabichi AL, Strom SS, Collins R, Meyers CA, Lippman SM. Brewster AM, et al. Among authors: clifford jl. J Clin Oncol. 2007 May 20;25(15):1974-8. doi: 10.1200/JCO.2006.05.9873. J Clin Oncol. 2007. PMID: 17513803 Clinical Trial.

2

Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.

Shin DM, Glisson BS, Khuri FR, Clifford JL, Clayman G, Benner SE, Forastiere AA, Ginsberg L, Liu D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK, Lippman SM. Shin DM, et al. Among authors: clifford jl. J Clin Oncol. 2002 Jan 15;20(2):364-70. doi: 10.1200/JCO.2002.20.2.364. J Clin Oncol. 2002. PMID: 11786562 Clinical Trial.

3

Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis.

Clifford JL, Walch E, Yang X, Xu X, Alberts DS, Clayman GL, El-Naggar AK, Lotan R, Lippman SM. Clifford JL, et al. Clin Cancer Res. 2002 Jul;8(7):2067-72. Clin Cancer Res. 2002. PMID: 12114405 Clinical Trial.

4

Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.

Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP 3rd, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM. Sabichi AL, et al. Among authors: clifford jl. Clin Cancer Res. 2008 Jan 1;14(1):224-9. doi: 10.1158/1078-0432.CCR-07-0733. Clin Cancer Res. 2008. PMID: 18172274 Clinical Trial.

5

Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skin.

Clifford JL, Menter DG, Yang X, Walch E, Zou C, Clayman GL, Schaefer TS, El-Naggar AK, Lotan R, Lippman SM. Clifford JL, et al. Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):993-7. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11008921

6

Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells.

Clifford JL, Yang X, Walch E, Wang M, Lippman SM. Clifford JL, et al. Mol Cancer Ther. 2003 May;2(5):453-9. Mol Cancer Ther. 2003. PMID: 12748307

7

Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.

Sabichi AL, Xu H, Fischer S, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Clifford JL. Sabichi AL, et al. Among authors: clifford jl. Clin Cancer Res. 2003 Oct 1;9(12):4606-13. Clin Cancer Res. 2003. PMID: 14555536

8

Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.

Clifford JL, Sabichi AL, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Lippman SM. Clifford JL, et al. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):391-5. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11319181

9

Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.

Clifford JL, Menter DG, Wang M, Lotan R, Lippman SM. Clifford JL, et al. Cancer Res. 1999 Jan 1;59(1):14-8. Cancer Res. 1999. PMID: 9892176

10

Identification and characterization of the human retinoid X receptor alpha gene promoter.

Li G, Yin W, Chamberlain R, Hewett-Emmett D, Roberts JN, Yang X, Lippman SM, Clifford JL. Li G, et al. Among authors: clifford jl. Gene. 2006 May 10;372:118-27. doi: 10.1016/j.gene.2005.12.027. Epub 2006 Mar 6. Gene. 2006. PMID: 16517099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters